Worth Venture Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,239
| Closed | -$315K | – | 150 |
|
|
2023
Q1 | $315K | Buy |
+3,239
| New | +$315K | 0.15% | 105 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 152 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 149 |
|
|
2021
Q2 | – | Sell |
-6,820
| Closed | -$515K | – | 107 |
|
|
2021
Q1 | $515K | Buy |
+6,820
| New | +$515K | 0.25% | 77 |
|
|
2020
Q2 | – | Sell |
-9,120
| Closed | -$771K | – | 99 |
|
|
2020
Q1 | $771K | Sell |
9,120
-13,880
| -60% | -$1.17M | 0.47% | 32 |
|
|
2019
Q4 | $1.95M | Buy |
23,000
+200
| +0.9% | +$16.9K | 0.95% | 16 |
|
|
2019
Q3 | $1.54M | Sell |
22,800
-4,500
| -16% | -$303K | 0.88% | 18 |
|
|
2019
Q2 | $2.34M | Sell |
27,300
-6,100
| -18% | -$523K | 1.3% | 14 |
|
|
2019
Q1 | $2.97M | Buy |
33,400
+23,000
| +221% | +$2.04M | 1.65% | 13 |
|
|
2018
Q4 | $886K | Buy |
+10,400
| New | +$886K | 0.67% | 28 |
|